Oestradiol supplement minimises coronary occlusion-induced myocardial infarction and ventricular dysfunction in oophorectomised female rats

International Journal of Cardiology

Volumn 151, Issue 3, 2011, Pages 290-295

  Zheng, Xiao Pu ^a   Ma, Ai Qun ^a   Dong, An Ping ^a   Wang, Shun ^a   Jiang, Wen Hui ^a   Wang, Ting Zhong ^a   Fan, Fen Ling ^a   Ling, Shanhong ^b  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Myocardial infarction; Oestradiol; Oestrogen receptor; Oopheroctomy; Ventricular dysfunction

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; PROTEIN BAX; RNA; THY 1 ANTIGEN; TROPONIN I;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ESTRADIOL BLOOD LEVEL; ESTROGEN THERAPY; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE FAILURE; HEMATOPOIETIC STEM CELL; HISTOPATHOLOGY; NONHUMAN; OVARIECTOMY; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; SUPPLEMENTATION; SYSTOLIC BLOOD PRESSURE;

ANIMALS; CARDIOTONIC AGENTS; CORONARY OCCLUSION; DIETARY SUPPLEMENTS; ESTRADIOL; FEMALE; MYOCARDIAL INFARCTION; OVARIECTOMY; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; VENTRICULAR DYSFUNCTION, LEFT;

EID: 80052763001     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.05.059     Document Type: Article

References (28)

1. S. Ling, P.A. Komesaroff, and K. Sudhir Cellular mechanisms underlying the cardiovascular actions of estrogens Clin Sci 111 2006 107 118 (Pubitemid 44220524)
2. W.C. Willett, M.J. Stampfer, B. Rosner, G.A. Colditz, C.H. Hennekens, and F.E. Speizer A prospective study of postmenopausal estrogen therapy and coronary heart disease N Engl J Med 313 1985 1044 1049 (Pubitemid 16243331)
3. F. Grodstein, G.A. Colditz, J.E. Manson, W.C. Willett, M.J. Stampfer, and F.E. Speizer A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease Ann Intern Med 133 2000 933 941 (Pubitemid 32003509)
4. S. Hulley, D. Grady, T. Bush, C. Furberg, D. Herrington, B. Riggs, and E. Vittinghoff Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in post-menopausal women JAMA 280 1998 605 613 (Pubitemid 28502636)
5. Writing Group for the Women's Health Institutive Investigators Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial JAMA 288 2002 321 333
6. T.B. Clarkson Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression Menopause 14 2007 373 384
7. B.V. Howard, L. Kuller, R. Langer, J.E. Manson, C. Allen, A. Assaf, B.B. Cochrane, J.C. Larson, N. Lasser, M. Rainford, L. Van Horn, M.L. Stefanick, and M. Trevisan Women's Health Initiative. Risk of cardiovascular disease by hysterectomy status, with and without oophorectomy: the Women's Health Initiative Observational Study Circulation 111 2005 1462 1470 (Pubitemid 40470639)
8. F. Atsma, M.E.L. Bartelink, D.E. Grobbee, and Y.T. Schouw Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis Menopause 13 2006 265 279
9. K. Bibbins-Domingo, F. Lin, E. Vittinghoff, E. Barrett-Connor, S.B. Hulley, D. Grady, and M.G. Shlipak Effect of hormone therapy on mortality rates among women with heart failure and coronary artery disease Am J Cardiol 95 2005 289 291 (Pubitemid 40092106)
10. K. Ytrehus, Y. Liu, A. Tsuhcida, T. Miura, G.S. Liu, X.M. Yang, D. Herbert, M.V. Cohen, and J.M. Downey Rat and rabbit heart infarction: effect of anesthesia, perfusate, risk zone, and method of infarct sizing Am J Physiol 267 1994 H2383 H2390
11. E.M. Antman, M.J. Tanasijevic, B. Thompson, M. Schactman, C.H. McCabe, C.P. Cannon, G.A. Fischer, A.Y. Fung, C. Thompson, D. Wybenga, and E. Braunwald Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes N Engl J Med 335 1996 1342 1349 (Pubitemid 26360452)
12. C. Grohe, S. Kahlert, K. Lobbert, M. Stimpel, R.H. Karas, H. Vetter, and L. Neyses Cardiac myocytes and fibroblasts contain functional estrogen receptors FEBS Lett 416 1997 107 112 (Pubitemid 27470812)
13. T. Pelzer, P.A. Loza, and K. Hu Increased mortality and aggravation of heart failure in estrogen receptor-β knockout mice after myocardial infarction Circulation 111 2005
14. T. Korte, M. Fuchs, and A. Arkudas Female mice lacking estrogen receptor β display prolonged ventricular repolarization and reduced ventricular automaticicty after myocardial infarction Circulation 111 2005 2282 2290 (Pubitemid 40647062)
15. F.A. Babiker, D.J. Lips, and E. Delvaux Oestrogen modulates cardiac ischaemic remodeling through oestrogen receptor-specific mechanisms Acta Physiol (Oxf) 189 2007 23 31 (Pubitemid 46092427)
16. S. Beer, M. Reincke, and M. Kral High-dose 17β-estuarial treatment prevents development of heart failure post-myocardial infarction in the rat Basic Res Cardiol 102 2007 9 18 (Pubitemid 44932767)
17. E.A. Booth, N.R. Obeid, and B.R. Lucchesi Activation of estrogen receptor-alpha protects the in vivo rabbit heart from ischemia-reperfusion injury Am J Physiol 289 2005 H2039 H2047 (Pubitemid 41507355)
18. S.I. Hale, Y. Birnbaum, and R.A. Kloner β-Estradiol, but not α-estradiol, reduces myocardial necrosis in rabbits after ischemia and reperfusion Am Heart J 132 1996 258 262 (Pubitemid 26292388)
19. K. Node, M. Kitakaze, H. Kosaka, T. Minamino, H. Funaya, and M. Hori Amelioration of ischemia and reperfusion-induced myocardial injury by 17β-estradiol Circulation 96 1997 1953 1963
20. E. Sbarouni, E. Iliodromitis, E. Bofilis, Z. Kyriakides, and D. Kremastinos Short-term estrogen reduces myocardial infarct size in oophorectomized female rabbits in a dose-dependent manner Cardiovasc Drugs Ther 12 1998 457 462 (Pubitemid 29002783)
21. E. Sbarouni, E. Iliodromitis, E. Bofilis, Z. Kyriakides, and D. Kremastinos Estrogen alone or combined with medroxyprogesterone but not raloxifene reduce myocardial infarct size Euro. J. Pharmacol. 467 2003 163 168 (Pubitemid 36423399)
22. E.A. Booth, N.R. Obeid, and B.R. Lucchesi Activation of estrogen receptor-alpha protects the in vivo rabbit heart from ischemia-reperfusion injury Am J Physiol 289 2005 H2039 H2047 (Pubitemid 41507355)
23. P.J.W. Smith, O. Ormatsky, D.J. Stewart, P. Picard, F. Dawood, W.H. Wen, P.P. Liu, D.J. Webb, and J.C. Monge Effects of estrogen replacement on infarct size, cardiac remodeling, and the endothelin system after myocardial infarction in ovariectomized rat Circulation 102 2000 2983 2989
24. I.H. Suparto, J.K. Williams, J.L. Fox, J.T. Yusuf, and D. Sajuthi Effects of hormone therapy and dietary soy on myocardial ischemia/reperfusion injury in ovariectomized atherosclerotic monkeys Menopause 15 2008 256 263 (Pubitemid 351354985)
25. J.Y. Min, Y. Yang, and K.L. Converso Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats J Appl Physiol 92 2002 288 296 (Pubitemid 34670018)
26. A.P. Beltrami, K. Urbanek, J. Kajstura, S.M. Yan, N. Finato, R. Bussani, B. Nadal-Ginard, F. Silvestri, A. Leri, C.A. Beltrami, and P. Anversa Evidence that human cardiac myocytes divide after myocardial infarction N. Engl. Med. 344 2001 1750 1757 (Pubitemid 32497029)
27. X.P. Zheng, A.Q. Ma, W. Zhang, A.P. Dong, R. Wang, and T. Geng Correlation of changes in circulating bone marrow stem cells in pregnant rabbits after acute myocardial infarction with serum estradiol J. South Med. Univ. 26 2006 237 239
28. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150